Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$17.69M$17.69Mderived+15.5% vs Q4 2022 Net Income-$237.19K-$237.19KderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$15,901,651+22.8% Operating Incomederived-$225,995N/M Operating Cash Flowderived-$848,532N/M Free Cash Flowderived-$902,808N/M Margins · derivedGross margin89.9%+5.4 pt vs Q4 2022
Operating margin-1.3%+19.1 pt vs Q4 2022
Net margin-1.3%+25.5 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 25, 2024 · 85 d after period end